Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Operating Expenses (2016 - 2025)

Organogenesis Holdings (ORGO) has 10 years of Operating Expenses data on record, last reported at $162.3 million in Q4 2025.

  • For Q4 2025, Operating Expenses rose 422.75% year-over-year to $162.3 million; the TTM value through Dec 2025 reached $519.5 million, up 348.83%, while the annual FY2025 figure was $519.5 million, 348.83% up from the prior year.
  • Operating Expenses reached $162.3 million in Q4 2025 per ORGO's latest filing, down from $239.8 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $239.8 million in Q3 2025 and bottomed at -$29.6 million in Q3 2024.
  • Average Operating Expenses over 5 years is $83.0 million, with a median of $77.6 million recorded in 2021.
  • Peak YoY movement for Operating Expenses: tumbled 139.68% in 2024, then soared 909.08% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $75.5 million in 2021, then grew by 5.53% to $79.7 million in 2022, then surged by 125.42% to $179.6 million in 2023, then tumbled by 82.71% to $31.1 million in 2024, then soared by 422.75% to $162.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $162.3 million in Q4 2025, $239.8 million in Q3 2025, and $27.6 million in Q2 2025.